SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-005800
Filing Date
2021-05-05
Accepted
2021-05-05 07:42:49
Documents
68
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q htbx-20210331x10q.htm 10-Q 1048555
2 EX-31.1 htbx-20210331ex311c6ece6.htm EX-31.1 15737
3 EX-31.2 htbx-20210331ex31200da37.htm EX-31.2 15748
4 EX-32.1 htbx-20210331ex321cf2a11.htm EX-32.1 7522
5 EX-32.2 htbx-20210331ex3228cf4d4.htm EX-32.2 7547
  Complete submission text file 0001558370-21-005800.txt   5751554

Data Files

Seq Description Document Type Size
6 EX-101.INS htbx-20210331.xml EX-101.INS 1199223
7 EX-101.SCH htbx-20210331.xsd EX-101.SCH 44094
8 EX-101.CAL htbx-20210331_cal.xml EX-101.CAL 72563
9 EX-101.DEF htbx-20210331_def.xml EX-101.DEF 126132
10 EX-101.LAB htbx-20210331_lab.xml EX-101.LAB 460404
11 EX-101.PRE htbx-20210331_pre.xml EX-101.PRE 336160
Mailing Address 627 DAVIS DRIVE SUITE 400 MORRISVILLE NC 27560
Business Address 627 DAVIS DRIVE SUITE 400 MORRISVILLE NC 27560 919-240-7133
HEAT BIOLOGICS, INC. (Filer) CIK: 0001476963 (see all company filings)

IRS No.: 262844103 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35994 | Film No.: 21891209
SIC: 2834 Pharmaceutical Preparations